ScholarIQanswers from OpenAlex

Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment

PaperCitations, authors & open-access status

Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment have?

ScholarIQcitation count

Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment has 77 citations in the OpenAlex counts ScholarIQ stores.

When was Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment published?

ScholarIQyear

Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment has 2019 year in the ScholarIQ index.

What is the open-access status of Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment?

ScholarIQoa status

Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment has gold oa status in the ScholarIQ index.

What is the DOI of Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment?

ScholarIQdoi

The DOI for Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment is on the source record.

What is the PMID of Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment?

ScholarIQpmid

The PMID for Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment is on the source record.

What is the OpenAlex record for Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment?

ScholarIQopenalex

The OpenAlex for Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial